NEUTROGUARD study: Phase III clinical study of DEFENCATH for prevention of CLABSI in adults on TPN via central venous catheter.

CorMedix Inc. (NASDAQ:CRMD) Q4 2025 Earnings Call Transcript March 5, 2026 CorMedix Inc. misses on earnings expectations.

Janus International Group, Inc. (NYSE:JBI) Q4 2025 Earnings Call Transcript March 5, 2026 Operator: Ladies and gentlemen, thank you for your continued patience. Your meeting will begin shortly. If you ...

Gaotu Techedu Inc. (NYSE:GOTU) Q4 2025 Earnings Call Transcript March 5, 2026 Gaotu Techedu Inc. beats earnings expectations.

Miller Industries, Inc. (NYSE:MLR) Q4 2025 Earnings Call Transcript March 5, 2026 Operator: Good day, ladies and gentlemen, and welcome to the Miller Industries, Inc. Fourth Quarter 2025 Results ...

All right. Good afternoon, everybody. So rounding off the corporate presentation today, we have KeyCorp. And we had Ken Gavrity. He is the Head of the Commercial Bank. And before he sits down with me ...

The company disclosed 2025 as one of its most profitable operational years, emphasizing new volume records for both core and ...

Following is the unofficial transcript of a CNBC exclusive interview with Paramount Skydance CEO David Ellison on CNBC's ...

As general contractor, SPIE will oversee the full project scope from planning to commissioning. This project will enhance grid reliability and support the integration of renewable energy, fully in ...

He also said, "I don't think any alternative to diplomacy is going to solve this problem." ...

On this "Face the Nation with Margaret Brennan" broadcast, Sens. Tom Cotton and Chris Murphy join Margaret Brennan.

Management reported rate-baseable assets increased by $70.0 million, or 59% across Santa Cruz Water Company and Palo Verde ...